Literature DB >> 16380546

Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study.

Amit Khera1, James A de Lemos, Ronald M Peshock, Hao S Lo, Harold G Stanek, Sabina A Murphy, Frank H Wians, Scott M Grundy, Darren K McGuire.   

Abstract

BACKGROUND: Elevated levels of C-reactive protein (CRP) are associated with increased risk for incident cardiovascular events on the basis of observations from several prospective epidemiological studies. However, less is known regarding the relationship between CRP levels and atherosclerotic burden. METHODS AND
RESULTS: We measured CRP in 3373 subjects 30 to 65 years of age who were participating in the Dallas Heart Study, a multiethnic, population-based, probability sample. Electron-beam CT scans were used to measure coronary artery calcification (CAC) in 2726 of these subjects, and MRI was used to measure aortic plaque in 2393. CRP levels were associated with most traditional cardiovascular risk factors. Subjects with CAC had higher median CRP levels than those without CAC (men: median, 2.4 versus 1.8 mg/L, P<0.001; women: median, 5.2 versus 3.6 mg/L, P<0.001), and there was a modest trend toward increasing CRP levels with increased CAC levels in men (P for trend=0.003) but not in women (P for trend=0.08). Male subjects with aortic plaque also had higher CRP levels than those without (median, 2.3 versus 1.8; P<0.001). In multivariate analysis adjusted for traditional cardiovascular risk factors, body mass index, and estrogen and statin medication use, the associations between CRP levels and CAC and CRP levels and aortic plaque were no longer statistically significant.
CONCLUSIONS: In a large, population-based sample, subjects with higher CRP levels had a modest increase in the prevalence of subclinical atherosclerosis, but this association was not independent of traditional cardiovascular risk factors. CRP is a poor predictor of atherosclerotic burden.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16380546     DOI: 10.1161/CIRCULATIONAHA.105.575241

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  57 in total

Review 1.  Primary prevention for patients with intermediate Framingham risk scores.

Authors:  Jason B Thompson; Juan J Rivera; Roger S Blumenthal; Peter Danyi
Journal:  Curr Cardiol Rep       Date:  2006-07       Impact factor: 2.931

Review 2.  Natriuretic peptides in the diagnosis and management of heart failure.

Authors:  G Michael Felker; John W Petersen; Daniel B Mark
Journal:  CMAJ       Date:  2006-09-12       Impact factor: 8.262

3.  Gender differences in the association of C-reactive protein with coronary artery calcium in type-2 diabetes.

Authors:  Atif N Qasim; Venkata Budharaju; Nehal N Mehta; Caitlin St Clair; Samira Farouk; Seth Braunstein; Mark Schutta; Nayyar Iqbal; Daniel J Rader; Muredach P Reilly
Journal:  Clin Endocrinol (Oxf)       Date:  2011-01       Impact factor: 3.478

4.  Comparison of characteristics of future myocardial infarctions in women with baseline high versus baseline low levels of high-sensitivity C-reactive protein.

Authors:  Sandeep Bansal; Paul M Ridker
Journal:  Am J Cardiol       Date:  2007-04-12       Impact factor: 2.778

Review 5.  Biomarkers of Calcific Aortic Valve Disease.

Authors:  Aeron Small; Daniel Kiss; Jay Giri; Saif Anwaruddin; Hasan Siddiqi; Marie Guerraty; Julio A Chirinos; Giovanni Ferrari; Daniel J Rader
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-02-02       Impact factor: 8.311

6.  Inflammation and coronary artery calcification in South Asians: The Mediators of Atherosclerosis in South Asians Living in America (MASALA) study.

Authors:  Anurag Mehta; Jaideep Patel; Mahmoud Al Rifai; Colby R Ayers; Ian J Neeland; Alka M Kanaya; Namratha Kandula; Michael J Blaha; Khurram Nasir; Roger S Blumenthal; Parag H Joshi
Journal:  Atherosclerosis       Date:  2018-01-31       Impact factor: 5.162

7.  Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia.

Authors:  Kevin C Oeffinger; Beverley Adams-Huet; Ronald G Victor; Timothy S Church; Peter G Snell; Andrea L Dunn; Debra A Eshelman-Kent; Robert Ross; Peter M Janiszewski; Alicia J Turoff; Sandra Brooks; Gloria Lena Vega
Journal:  J Clin Oncol       Date:  2009-06-29       Impact factor: 44.544

8.  Associations of four circulating chemokines with multiple atherosclerosis phenotypes in a large population-based sample: results from the dallas heart study.

Authors:  Leticia Castillo; Anand Rohatgi; Colby R Ayers; Andrew W Owens; Sandeep R Das; Amit Khera; Darren K McGuire; James A de Lemos
Journal:  J Interferon Cytokine Res       Date:  2010-05       Impact factor: 2.607

Review 9.  Importance of receptor-targeted systems in the battle against atherosclerosis.

Authors:  Elisabet Rosas; Igor Sobenin; Alexander Orekhov; Elazer R Edelman; Mercedes Balcells
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  Association of systemic inflammation with epicardial fat and coronary artery calcification.

Authors:  Sören Gauss; Lutz Klinghammer; Alina Steinhoff; Dorette Raaz-Schrauder; Mohamed Marwan; Stephan Achenbach; Christoph D Garlichs
Journal:  Inflamm Res       Date:  2015-03-13       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.